health biotech news today obesity drugs glp-1 Drugs, Digital & Trends in 2026 Novartis, Alector, Merck, Alnylm, UniQure

Preclinical data and clinical observations point to potential in chronic inflammatory conditions (like IBD) , persistent joint injuries, and even neuroprotective support

The numbers are not contradictory they answer different questions

GHK-Cu does not inhibit ghrelin, does not stimulate GLP-1 receptors, and does not meaningfully alter insulin sensitivity

Prescription-Only Product: Use only under professional supervision and as per medical/pharmacy protocols

Hydrophobic interactions are shown with solid red lines, ionic interactions are show with dotted red lines, and hydrogen bonding is indicated with dotted green lines